From the Journals

Waist-hip ratio a stronger mortality predictor than BMI


 

FROM JAMA NETWORK OPEN

TOPLINE:

Compared with body mass index, waist-hip ratio (WHR) had the strongest and most consistent association with all-cause mortality and was the only measurement unaffected by BMI.

METHODOLOGY:

  • Cohort study of incident deaths from the U.K. Biobank (2006-2022), including data from 22 centers across the United Kingdom.
  • A total of 387,672 participants were divided into a discovery cohort (n = 337,078) and validation cohort (n = 50,594), with the latter consisting of 25,297 deaths and 2,297 controls.
  • The discovery cohort was used to derive genetically determined adiposity measures while the validation cohort was used for analyses.
  • Exposure-outcome associations were analyzed through observational and mendelian randomization analyses.

TAKEAWAY:

  • In adjusted analysis, a J-shaped association was found for both measured BMI and fat mass index (FMI), whereas the association with WHR was linear (hazard ratio 1.41 per standard deviation increase).
  • There was a significant association between all three adiposity measures and all-cause mortality, with odds ratio 1.29 per SD change in genetically determined BMI (P = 1.44×10-13), 1.45 per SD change in genetically determined FMI, 1.45 (P = 6.27×10-30), and 1.51 per SD change in genetically determined WHR (P = 2.11×10-9).
  • Compared with BMI, WHR had the stronger association with all-cause mortality, although it was not significantly stronger than FMI.
  • The association of genetically determined BMI and FMI with all-cause mortality varied across quantiles of observed BMI, but WHR did not (P = .04, P = .02, and P = .58, for BMI, FMI, and WHR, respectively).

IN PRACTICE:

“Current World Health Organization recommendations for optimal BMI range are inaccurate across individuals with various body compositions and therefore suboptimal for clinical guidelines.”

SOURCE:

Study by Irfan Khan, MSc, of the Population Health Research Institute, David Braley Cardiac, Vascular, and Stroke Research Institute, Hamilton, Ont., and colleagues. Published online in JAMA Network Open.

LIMITATIONS:

Study population was genetically homogeneous, White, and British, so results may not be representative of other racial or ethnic groups.

DISCLOSURES:

Study was funded by, and Irfan Khan received support from, the Ontario Graduate Scholarship–Masters Scholarship, awarded by the government of Ontario.

A version of this article first appeared on Medscape.com.

Recommended Reading

Revised presentation of obesity may reduce internalized bias
Clinician Reviews
New weight loss drugs appeal to half of U.S. adults
Clinician Reviews
‘Water fasting’ benefits don’t last
Clinician Reviews
Certain genes predict abdominal fat regain after weight loss
Clinician Reviews
Artificial sweeteners no help for weight loss: Review
Clinician Reviews
It’s not ‘reckless’ to consider Ozempic
Clinician Reviews
Wegovy scores HFpEF benefits in people with obesity
Clinician Reviews
More weight loss linked with more benefit in STEP-HFpEF
Clinician Reviews
Obesity-related cardiovascular disease deaths surging
Clinician Reviews
‘New dawn’ for aldosterone as drug target in hypertension?
Clinician Reviews